Astellas

Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Thu, 03/23/23 - 11:41 am
Astellas
zolbetuximab
clinical trials
gastric cancer
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wed, 03/22/23 - 11:19 am
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Fri, 03/17/23 - 10:02 am
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Thu, 03/9/23 - 09:13 pm
Astellas
Xospata
AML
clinical trials
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Thu, 02/23/23 - 10:36 am
Astellas
Pompe disease
clinical trials
AT845
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Mon, 02/20/23 - 12:19 pm
Astellas
menopause
fezolinetant
FDA
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
ASCO GU
Pfizer
Astellas
Xtandi
prostate cancer
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Sun, 02/12/23 - 07:36 pm
Astellas
menopause
Super Bowl
DTC advertising
television ads
fezolinetant
Astellas Taps New CEO in Nod to Accelerated Growth
BioSpace
Mon, 02/6/23 - 10:56 am
Astellas
Pharma CEOs
Naoki Okamura
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Fierce Biotech
Fri, 01/20/23 - 10:24 am
Astellas
Pompe disease
gene therapy
AT845
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
Fri, 01/20/23 - 10:19 am
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
Wed, 01/11/23 - 10:51 am
cancer
oncology
Joe Biden
Astellas
Xtandi
prostate cancer
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
legal
Astellas
Pfizer
Lexiscan
patents
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Fri, 12/16/22 - 10:21 am
Astellas
clinical trials
zolbetuximab
gastric cancer
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Wed, 11/2/22 - 11:00 pm
Astellas
hot flashes
menopause
fezolinetant
patient education

Pages